======= CRLF3 ======= == Gene Information == * **Official Symbol**: CRLF3 * **Official Name**: cytokine receptor like factor 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51379|51379]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8IUI8|Q8IUI8]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CRLF3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CRLF3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/614853|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a cytokine receptor-like factor that may negatively regulate cell cycle progression at the G0/G1 phase. Studies of the related rat protein suggest that it may regulate neuronal morphology and synaptic vesicle biogenesis. This gene is one of several genes located in the neurofibromatosis type I tumor suppressor region on the q arm of chromosome 17, a region that is subject to microdeletions, duplications, chromosomal breaks and rearrangements. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2 and 5. [provided by RefSeq, Aug 2012]. * **UniProt Summary**: May play a role in the negative regulation of cell cycle progression. {ECO:0000269|PubMed:19427400}. No Pfam Domain information is available for this gene. |positive regulation of cell cycle arrest| |positive regulation of receptor signaling pathway via JAK-STAT| |positive regulation of receptor signaling pathway via STAT| |regulation of cell cycle arrest| |G1/S transition of mitotic cell cycle| |cell cycle G1/S phase transition| |regulation of receptor signaling pathway via JAK-STAT| |regulation of receptor signaling pathway via STAT| |negative regulation of cell growth| |negative regulation of growth| |mitotic cell cycle phase transition| |cell cycle phase transition| |positive regulation of cell cycle process| |positive regulation of cell cycle| |regulation of cell growth| |mitotic cell cycle process| |regulation of growth| |mitotic cell cycle| |regulation of cell cycle process| |cell cycle process| |identical protein binding| |regulation of cell cycle| |positive regulation of transcription by RNA polymerase II| |cell cycle| |DNA binding| |positive regulation of transcription, DNA-templated| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of signal transduction| |positive regulation of RNA metabolic process| |positive regulation of cell communication| |positive regulation of signaling| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp77|Prochlorperazine 5.2μM R02 exp77]]|1.7| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|1/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 17881 * **Expression level (log2 read counts)**: 5.51 {{:chemogenomics:nalm6 dist.png?nolink |}}